{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-111947","form_type":"8-K","ticker":"CARL","cik":"0001794546","company_name":"CARLSMED, INC.","filed_at":"2025-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.012645+00:00","generated_at":"2026-05-17T09:30:00.887191+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Carlsmed Q2 revenue $12.1M (+99% YoY); raises FY guidance to $45.5M-$47.5M","bullets":["Q2 revenue $12.1M, up 99% YoY; gross margin 73.4%; net loss $6.8M.","Cash $33.5M at June 30; $93.5M net from July 2025 IPO to fund growth.","First personalized cervical spine surgery using aprevo completed; CMS NTAP reimbursement begins Oct 1, 2025.","FY 2025 revenue guidance raised to $45.5M-$47.5M, representing 67-75% growth YoY.","Adjusted EBITDA loss unchanged at $6.2M; operating expenses rose to $15.4M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-111947","json":"https://secwatch.observer/filing/0000950170-25-111947.json","markdown":"https://secwatch.observer/filing/0000950170-25-111947.md","text":"https://secwatch.observer/filing/0000950170-25-111947.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1794546/000095017025111947/0000950170-25-111947-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1794546/000095017025111947/carl-20250828.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:30:00.887191+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}